Eton Pharmaceuticals (ETON) Operating Leases (2019 - 2025)
Historic Operating Leases for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to $480000.0.
- Eton Pharmaceuticals' Operating Leases rose 28095.24% to $480000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $480000.0, marking a year-over-year increase of 28095.24%. This contributed to the annual value of $107000.0 for FY2024, which is 38636.36% up from last year.
- As of Q3 2025, Eton Pharmaceuticals' Operating Leases stood at $480000.0, which was up 28095.24% from $492000.0 recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Operating Leases ranged from a high of $492000.0 in Q2 2025 and a low of $15000.0 during Q4 2021
- In the last 5 years, Eton Pharmaceuticals' Operating Leases had a median value of $79000.0 in 2021 and averaged $116315.8.
- Per our database at Business Quant, Eton Pharmaceuticals' Operating Leases plummeted by 8484.85% in 2021 and then surged by 61333.33% in 2022.
- Over the past 5 years, Eton Pharmaceuticals' Operating Leases (Quarter) stood at $15000.0 in 2021, then surged by 613.33% to $107000.0 in 2022, then tumbled by 79.44% to $22000.0 in 2023, then soared by 386.36% to $107000.0 in 2024, then soared by 348.6% to $480000.0 in 2025.
- Its last three reported values are $480000.0 in Q3 2025, $492000.0 for Q2 2025, and $87000.0 during Q1 2025.